GLP-1 market may be smaller than expected, says Lupin; plans next wave of weight-loss drugs
The drugmaker is planning fortnightly bofenglutide and is looking to expand semaglutide to overseas markets.
This article was aggregated from Business Today. Continue reading for the complete story.
Read on Business Today